[Form 4] Tivic Health Systems, Inc. Insider Trading Activity
Tivic Health Systems director Zikria Dean was granted a stock option to purchase 7,500 shares of common stock on 08/06/2025 at an exercise price of $3.32. The option vests in four equal quarterly installments, with 100% vesting upon the first anniversary of the grant, and expires on 08/05/2035. Following the reported transaction the reporting person directly beneficially owns 7,500 derivative securities representing the right to acquire 7,500 shares.
This Form 4 reports a non-cash equity award to an insider: the grant establishes the right to purchase common stock at a fixed price and details the vesting timetable and expiration date.
Il direttore di Tivic Health Systems, Zikria Dean, ha ricevuto un'opzione su azioni per acquistare 7.500 azioni ordinarie il 08/06/2025 a un prezzo di esercizio di $3,32. L'opzione matura in quattro rate trimestrali uguali, con il 100% delle azioni maturate al primo anniversario della concessione, e scade il 08/05/2035. A seguito della transazione segnalata, la persona che effettua la comunicazione detiene direttamente 7.500 strumenti derivati che rappresentano il diritto ad acquisire 7.500 azioni.
Questo Modulo 4 segnala un premio azionario non monetario concesso a un insider: la sovvenzione stabilisce il diritto di acquistare azioni ordinarie a un prezzo fisso e ne dettaglia il calendario di maturazione e la data di scadenza.
La directora de Tivic Health Systems, Zikria Dean, recibi贸 una opci贸n sobre acciones para comprar 7.500 acciones ordinarias el 08/06/2025 a un precio de ejercicio de $3,32. La opci贸n se consolida en cuatro cuotas trimestrales iguales, con el 100% consolidado al primer aniversario de la concesi贸n, y expira el 08/05/2035. Tras la operaci贸n comunicada, la persona informante posee directamente 7.500 valores derivados que representan el derecho a adquirir 7.500 acciones.
Este Formulario 4 informa sobre una asignaci贸n de capital no dineraria a un insider: la concesi贸n establece el derecho a comprar acciones ordinarias a un precio fijo y detalla el calendario de consolidaci贸n y la fecha de vencimiento.
Tivic Health Systems 鞚挫偓 Zikria Dean鞚� 2025雲� 08/06鞚检棎 氤错喌欤� 7,500欤茧ゼ 毵れ垬頃� 靾� 鞛堧姅 鞀ろ啞鞓奠厴鞚� 頄夓偓臧� $3.32搿� 攵�鞐皼鞎橃姷雼堧嫟. 頃措嫻 鞓奠厴鞚� 霃欖澕頃� 攵勱赴氤� 4須� 攵勴暊搿� 甓岆Μ臧� 旆摑霅橂┌, 攵�鞐澕搿滊秬韯� 1欤茧厔 鞁滌爯鞐� 100% 甓岆Μ 旆摑鞚� 鞚措（鞏挫瓿�, 毵岆鞚检潃 2035雲� 08/05鞚检瀰雼堧嫟. 鞁犼碃霅� 瓯半灅 鞚错泟 氤搓碃鞚胳潃 氤错喌欤� 7,500欤茧ゼ 旆摑頃� 甓岆Μ毳� 雮橅儉雮措姅 韺岇儩歃濌秾 7,500欤茧ゼ 歆侅爲鞝侅溂搿� 鞁れ 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
鞚� Form 4電� 雮措秬鞛愳棎 雽�頃� 順勱笀鞚� 鞎勲媽 欤检嫕氤挫儊 靾橃棳毳� 氤搓碃頃╇媹雼�: 頃措嫻 靾橃棳電� 瓿犾爼 臧�瓴╈溂搿� 氤错喌欤茧ゼ 毵れ垬頃� 甓岆Μ毳� 靹れ爼頃橂┌ 甓岆Μ 旆摑 鞚检爼瓿� 毵岆鞚检潉 氇呾嫓頃╇媹雼�.
La directrice de Tivic Health Systems, Zikria Dean, s'est vue accorder le 08/06/2025 une option d'achat portant sur 7 500 actions ordinaires au prix d'exercice de 3,32 $. L'option s'acquiert par quatre trimestres 茅gaux, avec une acquisition 脿 100 % au premier anniversaire de l'attribution, et expire le 08/05/2035. 脌 la suite de l'op茅ration d茅clar茅e, la personne d茅clarante d茅tient directement 7 500 titres d茅riv茅s repr茅sentant le droit d'acqu茅rir 7 500 actions.
Ce formulaire 4 signale une attribution d'actions non mon茅taire 脿 un initi茅聽: l'attribution 茅tablit le droit d'acheter des actions ordinaires 脿 un prix fixe et pr茅cise le calendrier d'acquisition ainsi que la date d'expiration.
Tivic Health Systems-Direktorin Zikria Dean wurde am 08/06/2025 eine Aktienoption zum Kauf von 7.500 Stammaktien zu einem Aus眉bungspreis von $3,32 gew盲hrt. Die Option wird in vier gleichen viertelj盲hrlichen Raten unverfallbar, wobei 100 % zum ersten Jahrestag der Gew盲hrung unverfallbar sind, und sie verf盲llt am 08/05/2035. Nach der gemeldeten Transaktion besitzt die meldepflichtige Person direkt 7.500 derivative Wertpapiere, die das Recht zum Erwerb von 7.500 Aktien darstellen.
Dieses Formular 4 meldet eine nicht in bar erfolgte Aktienzuteilung an einen Insider: Die Gew盲hrung begr眉ndet das Recht, Stammaktien zu einem festen Preis zu erwerben, und nennt den Vesting-Zeitplan sowie das Ablaufdatum.
- Grant of 7,500 stock options to a director is explicitly disclosed
- Exercise price documented at $3.32, providing clear terms
- Vesting schedule specified: four equal quarterly installments with full vesting by first anniversary
- Expiration date provided: 08/05/2035, clarifying option term
- None.
Insights
TL;DR: Director received a time鈥慴ased option grant of 7,500 shares with full vesting within one year; routine insider compensation disclosure.
The Form 4 documents a standard director equity award: a stock option with an exercise price of $3.32 covering 7,500 shares, vesting in four equal quarterly installments and fully vested by the first anniversary. The option expires on 08/05/2035 and is reported as directly beneficially owned following the acquisition. From a governance perspective this is a routine disclosure that clarifies insider holdings and the schedule under which equity becomes exercisable.
TL;DR: 7,500 options at $3.32 granted to a director; the economical impact depends on company share count and future stock performance.
The filing shows an acquisition coded as an option grant (Transaction Code A) for 7,500 stock options with a $3.32 exercise price, exercisable per the stated quarterly vesting schedule and expiring in 2035. The report confirms direct beneficial ownership of 7,500 derivative securities after the grant. The document provides the core terms investors use to model potential dilution and future insider exercise scenarios, but does not include share count or pro forma dilution figures.
Il direttore di Tivic Health Systems, Zikria Dean, ha ricevuto un'opzione su azioni per acquistare 7.500 azioni ordinarie il 08/06/2025 a un prezzo di esercizio di $3,32. L'opzione matura in quattro rate trimestrali uguali, con il 100% delle azioni maturate al primo anniversario della concessione, e scade il 08/05/2035. A seguito della transazione segnalata, la persona che effettua la comunicazione detiene direttamente 7.500 strumenti derivati che rappresentano il diritto ad acquisire 7.500 azioni.
Questo Modulo 4 segnala un premio azionario non monetario concesso a un insider: la sovvenzione stabilisce il diritto di acquistare azioni ordinarie a un prezzo fisso e ne dettaglia il calendario di maturazione e la data di scadenza.
La directora de Tivic Health Systems, Zikria Dean, recibi贸 una opci贸n sobre acciones para comprar 7.500 acciones ordinarias el 08/06/2025 a un precio de ejercicio de $3,32. La opci贸n se consolida en cuatro cuotas trimestrales iguales, con el 100% consolidado al primer aniversario de la concesi贸n, y expira el 08/05/2035. Tras la operaci贸n comunicada, la persona informante posee directamente 7.500 valores derivados que representan el derecho a adquirir 7.500 acciones.
Este Formulario 4 informa sobre una asignaci贸n de capital no dineraria a un insider: la concesi贸n establece el derecho a comprar acciones ordinarias a un precio fijo y detalla el calendario de consolidaci贸n y la fecha de vencimiento.
Tivic Health Systems 鞚挫偓 Zikria Dean鞚� 2025雲� 08/06鞚检棎 氤错喌欤� 7,500欤茧ゼ 毵れ垬頃� 靾� 鞛堧姅 鞀ろ啞鞓奠厴鞚� 頄夓偓臧� $3.32搿� 攵�鞐皼鞎橃姷雼堧嫟. 頃措嫻 鞓奠厴鞚� 霃欖澕頃� 攵勱赴氤� 4須� 攵勴暊搿� 甓岆Μ臧� 旆摑霅橂┌, 攵�鞐澕搿滊秬韯� 1欤茧厔 鞁滌爯鞐� 100% 甓岆Μ 旆摑鞚� 鞚措（鞏挫瓿�, 毵岆鞚检潃 2035雲� 08/05鞚检瀰雼堧嫟. 鞁犼碃霅� 瓯半灅 鞚错泟 氤搓碃鞚胳潃 氤错喌欤� 7,500欤茧ゼ 旆摑頃� 甓岆Μ毳� 雮橅儉雮措姅 韺岇儩歃濌秾 7,500欤茧ゼ 歆侅爲鞝侅溂搿� 鞁れ 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
鞚� Form 4電� 雮措秬鞛愳棎 雽�頃� 順勱笀鞚� 鞎勲媽 欤检嫕氤挫儊 靾橃棳毳� 氤搓碃頃╇媹雼�: 頃措嫻 靾橃棳電� 瓿犾爼 臧�瓴╈溂搿� 氤错喌欤茧ゼ 毵れ垬頃� 甓岆Μ毳� 靹れ爼頃橂┌ 甓岆Μ 旆摑 鞚检爼瓿� 毵岆鞚检潉 氇呾嫓頃╇媹雼�.
La directrice de Tivic Health Systems, Zikria Dean, s'est vue accorder le 08/06/2025 une option d'achat portant sur 7 500 actions ordinaires au prix d'exercice de 3,32 $. L'option s'acquiert par quatre trimestres 茅gaux, avec une acquisition 脿 100 % au premier anniversaire de l'attribution, et expire le 08/05/2035. 脌 la suite de l'op茅ration d茅clar茅e, la personne d茅clarante d茅tient directement 7 500 titres d茅riv茅s repr茅sentant le droit d'acqu茅rir 7 500 actions.
Ce formulaire 4 signale une attribution d'actions non mon茅taire 脿 un initi茅聽: l'attribution 茅tablit le droit d'acheter des actions ordinaires 脿 un prix fixe et pr茅cise le calendrier d'acquisition ainsi que la date d'expiration.
Tivic Health Systems-Direktorin Zikria Dean wurde am 08/06/2025 eine Aktienoption zum Kauf von 7.500 Stammaktien zu einem Aus眉bungspreis von $3,32 gew盲hrt. Die Option wird in vier gleichen viertelj盲hrlichen Raten unverfallbar, wobei 100 % zum ersten Jahrestag der Gew盲hrung unverfallbar sind, und sie verf盲llt am 08/05/2035. Nach der gemeldeten Transaktion besitzt die meldepflichtige Person direkt 7.500 derivative Wertpapiere, die das Recht zum Erwerb von 7.500 Aktien darstellen.
Dieses Formular 4 meldet eine nicht in bar erfolgte Aktienzuteilung an einen Insider: Die Gew盲hrung begr眉ndet das Recht, Stammaktien zu einem festen Preis zu erwerben, und nennt den Vesting-Zeitplan sowie das Ablaufdatum.
FAQ
What did Tivic Health (TIVC) report in this Form 4?
How does the option vest for the grant reported by TIVC?
When does the option expire and how many shares underlie it?
What is the ownership form reported for the derivative securities?
What transaction code and type are shown on the Form 4 for this grant?
